The chemotherapy of rodent malaria
- 1 January 1989
- journal article
- research article
- Published by Taylor & Francis in Pathogens and Global Health
- Vol. 83 (1) , 1-10
- https://doi.org/10.1080/00034983.1989.11812304
Abstract
CM 6606 differs in its mode of action from chloroquine but studies on its activity against parasites resistant to other antimalarials suggest that it may have some features in common with aminoalcohols. Similarities in drug-induced pigment changes are especially striking. Only halofantrine shows a reduced activity, however, against parasites that are highly resistant to CM 6606, while such parasites are slightly hypersensitive to sulfadoxine and clindamycin. Evidence suggesting that CM 6606 may function through an active metabolite, possibly CM 6609 in which the N-oxide is reduced, is discussed.Keywords
This publication has 9 references indexed in Scilit:
- The chemotherapy of rodent malaria XLIII. Indolo (3,2-c)quinoline-N-oxidesPathogens and Global Health, 1988
- The chemotherapy of rodent malaria XLII. Halofantrine and halofantrine resistancePathogens and Global Health, 1987
- The chemotherapy of rodent malaria XLIPathogens and Global Health, 1986
- The chemotherapy of rodent malaria, XLPathogens and Global Health, 1986
- Qinghaosu resistance in rodent malariaTransactions of the Royal Society of Tropical Medicine and Hygiene, 1986
- The chemotherapy of rodent malaria, XXXIXPathogens and Global Health, 1985
- The chemotherapy of rodent malaria XXXIIIPathogens and Global Health, 1982
- Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution techniqueAntimicrobial Agents and Chemotherapy, 1979
- The chemotherapy of rodent malaria, XXVII Studies on mefloquine (WR 142,490)Pathogens and Global Health, 1977